by Lance Smith | Mar 19, 2020 | Study Scavenger Clinical Trial Recruitment Platform
SOUTH SAN FRANCISCO, Calif., March 18, 2020 /PRNewswire/ — Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced proactive steps the Company is taking in support of public heath efforts to prevent furtherspread of coronavirus (or COVID-19) around the...by Lance Smith | Mar 19, 2020 | Study Scavenger Clinical Trial Recruitment Platform
Successfully completes single ascending dose phase of first clinical study in healthy subjects for a direct-to-lung, Thin Film Freezing (TFF) dry-powder formulation Invasive Pulmonary Aspergillosis is a severe fungal pulmonary disease with a mortality rate that can...by Lance Smith | Mar 19, 2020 | Study Scavenger Clinical Trial Recruitment Platform
VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that Novotech, a...by Lance Smith | Mar 19, 2020 | Study Scavenger Clinical Trial Recruitment Platform
– Final Analysis Comparing 10 AllocetraTM-Treated Patients with 37 Matched Controls Showed Significant Positive Responses in State of Organ Failure, ICU Hospitalization and Mortality in a Highly Fragile and Extremely Difficult to Treat Population with Severe Sepsis –...by Lance Smith | Mar 19, 2020 | Study Scavenger Clinical Trial Recruitment Platform
AGOURA HILLS, Calif., March 18, 2020 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc., (OTCQB:MATN) (“Mateon”) dedicated to development OT-101, a TGF-Beta antisense drug candidate, today provided an update on its rapid antiviral response program against...